Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Hongene to supply exNA oligonucleotide technology under new licensing deal

    Aug 28, 2025, 10:01 AM by
    Full story
  • DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion

    Aug 28, 2025, 10:01 AM by
    Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
    Full story
  • Ultima’s ppmSeq Pushes Sequencing to New Levels of Accuracy

    Aug 28, 2025, 01:00 AM by User Not Found
    Bio-IT World| Ultima Genomics unveiled updates on the single-nucleotide variant (SNV) detection capabilities of its plus-minus sequencing (ppmSeq) technology, which were published at bioRxiv. The updates elaborate beyond the limits of currently available minimal residual disease assays.
    Full story
  • Huateng Pharma Expands Cosmetic Ingredients Portfolio with Reliable, Ready-to-Ship Actives

    Aug 27, 2025, 08:24 AM by
    Huateng Pharma offers reliable cosmetic ingredients including Diethylamino Hydroxybenzoyl Hexyl Benzoate, Tetrahydrocurcumin, and Piroctone Olamine.
    Full story
  • Follow the Money: Rheumatoid Arthritis Therapy, Novel Next-Gen Biosensor, More

    Aug 27, 2025, 01:00 AM by User Not Found
    Bio-IT World| SetPoint Medical will advance commercialization of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for adults living with moderate-to-severe rheumatoid arthritis; Sava Technologies plan to accelerate regulatory approval and commercialization of its next-generation wearable; and more.
    Full story
  • BioMed X, Novo Nordisk Collaboration, 10x Genomics Launches Platform Addition, More

    Aug 26, 2025, 01:00 AM by User Not Found
    Bio-IT World| BioMed X announced the launch of a new collaboration with Novo Nordisk; 10x Genomics launched Xenium Protein, a new addition to its Xenium Spatial platform; and more.
    Full story
  • eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform

    Aug 22, 2025, 09:17 AM by
    Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
    Full story
  • Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

    Aug 21, 2025, 09:06 AM by
    Full story
  • ZeOmega Launches Smart Auth Optimizer to Transform Prior Authorization

    Aug 21, 2025, 09:06 AM by
    Full story
  • Bioprocessing Summit Honors LISURE as Best of Show Winner

    Aug 21, 2025, 01:00 AM by User Not Found
    Bio-IT World | During this week’s Bioprocessing Summit in Boston, M++ UltraPilot from LISURE was named the winner of the Best of Show People’s Choice Award competition. Other finalists and their products were also named and featured.
    Full story
  • Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials

    Aug 20, 2025, 09:21 AM by
    MMS, a global has announced that it has been chosen by Friends of Cancer Research to support the development of practical decision frameworks to inform the interpretation of interim overall survival data in oncology clinical trials.
    Full story
  • Family-Based Genomics Benchmark Promises More Accurate Variant Detection

    Aug 20, 2025, 01:00 AM by User Not Found
    Bio-IT World | A multi-generational family tree is helping researchers dramatically improve the accuracy of genomic variant calling, according to a new study published in Nature Methods. The research, led by scientists at Pacific Biosciences, introduces a comprehensive benchmarking dataset that could reshape how genomic technologies are trained and validated.
    Full story
  • Nature’s Most Promising Bioactives to Speed Up Evidence-Based Drug Discovery

    Aug 19, 2025, 01:00 AM by User Not Found
    Bio-IT World | Natural products and medicines mimicking substances found in nature have been used clinically for well over 100 years and could help remedy what ails today’s alarmingly long and relatively unproductive drug discovery process. Since bioactive substances from natural resources have a track record of use against disease, they are a compelling starting point for evidence-based discovery of novel human therapies.
    Full story
  • Ambience Healthcare Joins Epic Toolbox, Unlocking Advanced AI Functionality Within Haiku for Epic Customers

    Aug 18, 2025, 09:19 AM by
    Full story
  • Transforming Parkinson’s Disease Treatment , Insilico Medicine Announces IND-enabling Completion for AI-empowered Oral NLRP3 Inhibitor ISM8969

    Aug 15, 2025, 09:25 AM by
    Insilico Medicine has completed IND-enabling studies for ISM8969 the oral NLRP3 inhibitor, and plans to submit the Investigational New Drug (IND) application in the fourth quarter of 2025 to begin clinical validation. Based on the potential of ISM8969 against neurodegenerative disorders, as demonstrated in pre-clinical studies, the drug candidate will be evaluated as a novel option for Parkinson’s disease (PD) treatment. Empowered by Insilico Medicine’s Pharma.AI platform, ISM8969 demonstrated favorable PD/PK profiles, as well as dose-dependent efficacy in motor functions in animal models.
    Full story
  • TetraScience Launches Tetra Workflows to Automate Scientific Data Workflows at Scale

    Aug 15, 2025, 09:25 AM by
    Tetra Workflows enables laboratories to orchestrate and automate data workflows from instruments to lab informatics software at unprecedented scale and reliability. The platform encompasses the entire journey of scientific data, from initial collection and input through storage, analysis, and reporting, ensuring data quality, reliability, consistency, traceability, and efficiency throughout the process.
    Full story
  • ZeOmega and Clearlink Partners Unite to Streamline Delegated Clinical Services

    Aug 15, 2025, 09:25 AM by
    Full story
  • Cotiviti Welcomes Veteran Healthcare Technology Growth Leader Robert Kopanic as Chief Revenue Officer

    Aug 15, 2025, 09:25 AM by
    Full story
  • Firstsource and Guidehealth Partner to Accelerate AI-Enabled Value-Based Care Innovation for Health Plans

    Aug 14, 2025, 09:23 AM by
    Full story
  • Syncell Announces Strategic Co-Marketing Agreement to Advance High-Resolution Spatial Proteomics

    Aug 14, 2025, 09:23 AM by
    Syncell and Thermo Fisher Scientific are working together to bring a fully integrated, high-resolution spatial proteomics workflow to the market.
    Full story
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy